Literature DB >> 28253546

Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.

Bernard J Hanseeuw1,2, Rebecca A Betensky3, Aaron P Schultz1, Kathryn V Papp1,4, Elizabeth C Mormino1, Jorge Sepulcre2, John S Bark2, Danielle M Cosio2, Molly LaPoint1, Jasmeer P Chhatwal1, Dorene M Rentz1,4, Reisa A Sperling1,4, Keith A Johnson1,2,4.   

Abstract

OBJECTIVE: The aim of this article was to evaluate in normal older adults and preclinical Alzheimer's disease (AD) the impact of amyloid and regional tauopathy on cerebral glucose metabolism and subsequent memory decline.
METHODS: We acquired positron emission tomography using F18 flortaucipir (tau), C11 Pittsburgh compound B (amyloid), and F18 fluorodeoxyglucose (FDG) in 90 clinically normal elderly of the Harvard Aging Brain Study.
RESULTS: Posterior cingulate metabolism decreased when both amyloid and neocortical tau were high and predicted subsequent memory decline in a larger sample of normal elderly. In contrast, frontal hypometabolism related to the common age-related entorhinal tauopathy, but this dysfunction was independent of amyloid, and did not predict significant memory decline. Neocortical tauopathy was positively associated with metabolism in individuals with subthreshold amyloid, suggesting that glucose metabolism increases before decreasing in the course of preclinical AD.
INTERPRETATION: Our study identified a synergistic effect of amyloid and tau deposits and demonstrated, for the first time, in normal elderly its link to AD-like hypometabolism and to AD-like memory decline. The amyloid effect was observed with tau in neocortex, but not with tau in entorhinal cortex, which is the common site of age-related tauopathy. Entorhinal tau was associated with frontal hypometabolism, but this dysfunction was not associated with memory loss. Ann Neurol 2017;81:583-596.
© 2017 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28253546      PMCID: PMC5404378          DOI: 10.1002/ana.24910

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

1.  Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.

Authors:  K Meguro; X Blaizot; Y Kondoh; C Le Mestric; J C Baron; C Chavoix
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

Authors:  M J de Leon; A Convit; O T Wolf; C Y Tarshish; S DeSanti; H Rusinek; W Tsui; E Kandil; A J Scherer; A Roche; A Imossi; E Thorn; M Bobinski; C Caraos; P Lesbre; D Schlyer; J Poirier; B Reisberg; J Fowler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

3.  Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.

Authors:  Igor Yakushev; Matthias J Muller; Hans-Georg Buchholz; Ulrike Lang; Heidi Rossmann; Harald Hampel; Mathias Schreckenberger; Andreas Fellgiebel
Journal:  Curr Alzheimer Res       Date:  2012-02       Impact factor: 3.498

4.  The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.

Authors:  N Maritza Dowling; Sterling C Johnson; Carey E Gleason; William J Jagust
Journal:  Neuroimage       Date:  2014-10-29       Impact factor: 6.556

5.  Frontal lobe damage produces episodic memory impairment.

Authors:  M A Wheeler; D T Stuss; E Tulving
Journal:  J Int Neuropsychol Soc       Date:  1995-11       Impact factor: 2.892

6.  FDG PET imaging in patients with pathologically verified dementia.

Authors:  J M Hoffman; K A Welsh-Bohmer; M Hanson; B Crain; C Hulette; N Earl; R E Coleman
Journal:  J Nucl Med       Date:  2000-11       Impact factor: 10.057

Review 7.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

8.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

9.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  63 in total

1.  Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data.

Authors:  Lexin Li; Jian Kang; Samuel N Lockhart; Jenna Adams; William J Jagust
Journal:  IEEE Trans Med Imaging       Date:  2018-07-18       Impact factor: 10.048

Review 2.  Imaging the evolution and pathophysiology of Alzheimer disease.

Authors:  William Jagust
Journal:  Nat Rev Neurosci       Date:  2018-11       Impact factor: 34.870

3.  Functional and Pathological Correlates of Judgments of Learning in Cognitively Unimpaired Older Adults.

Authors:  Federico d'Oleire Uquillas; Heidi I L Jacobs; Aaron P Schultz; Bernard J Hanseeuw; Rachel F Buckley; Jorge Sepulcre; Alvaro Pascual-Leone; Nancy J Donovan; Keith A Johnson; Reisa A Sperling; Patrizia Vannini
Journal:  Cereb Cortex       Date:  2020-03-14       Impact factor: 5.357

4.  PET imaging of tau protein targets: a methodology perspective.

Authors:  Cristina Lois; Ivan Gonzalez; Keith A Johnson; Julie C Price
Journal:  Brain Imaging Behav       Date:  2019-04       Impact factor: 3.978

5.  Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer's disease.

Authors:  Matthieu Vanhoutte; Franck Semah; Xavier Leclerc; Adeline Rollin Sillaire; Alice Jaillard; Grégory Kuchcinski; Xavier Delbeuck; Rachid Fahmi; Florence Pasquier; Renaud Lopes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

6.  Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Authors:  Rik Ossenkoppele; Gil D Rabinovici; Ruben Smith; Hanna Cho; Michael Schöll; Olof Strandberg; Sebastian Palmqvist; Niklas Mattsson; Shorena Janelidze; Alexander Santillo; Tomas Ohlsson; Jonas Jögi; Richard Tsai; Renaud La Joie; Joel Kramer; Adam L Boxer; Maria L Gorno-Tempini; Bruce L Miller; Jae Y Choi; Young H Ryu; Chul H Lyoo; Oskar Hansson
Journal:  JAMA       Date:  2018-09-18       Impact factor: 56.272

7.  Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults.

Authors:  Jenna N Adams; Samuel N Lockhart; Lexin Li; William J Jagust
Journal:  Cereb Cortex       Date:  2019-05-01       Impact factor: 5.357

8.  The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.

Authors:  Reisa A Sperling; Elizabeth C Mormino; Aaron P Schultz; Rebecca A Betensky; Kathryn V Papp; Rebecca E Amariglio; Bernard J Hanseeuw; Rachel Buckley; Jasmeer Chhatwal; Trey Hedden; Gad A Marshall; Yakeel T Quiroz; Nancy J Donovan; Jonathan Jackson; Jennifer R Gatchel; Jennifer S Rabin; Heidi Jacobs; Hyun-Sik Yang; Michael Properzi; Dylan R Kirn; Dorene M Rentz; Keith A Johnson
Journal:  Ann Neurol       Date:  2019-01-21       Impact factor: 10.422

9.  Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.

Authors:  Murat Bilgel; Yang An; Jessica Helphrey; Wendy Elkins; Gabriela Gomez; Dean F Wong; Christos Davatzikos; Luigi Ferrucci; Susan M Resnick
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

10.  Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.

Authors:  Daniel Albrecht; A Lisette Isenberg; Joy Stradford; Teresa Monreal; Abhay Sagare; Maricarmen Pachicano; Melanie Sweeney; Arthur Toga; Berislav Zlokovic; Helena Chui; Elizabeth Joe; Lon Schneider; Peter Conti; Kay Jann; Judy Pa
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.